EUVIMEDEUVIMED entdecken
Crossref

Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway

Jianchao He, Yuhui Bu, Xiaolong Li, Xiaojun Zhang, Li Ma

Biological and Pharmaceutical Bulletin · 2023

DOI: 10.1248/bpb.b22-00602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Jianchao He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, the Fourth Hospital of Hebei Medical University. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is the most generally diagnosed cancer and the driving cause of cancer-related death. Transmembrane (TMEM) proteins have been reported to serve as prognostic indicators in a variety of cancers, and it can offer therapeutic targets for carcinoma. However, the function of TMEM in BC remains unclear. In this study, TMEM9A, a member of TMEM family, was screened as the candidate gene after analyzing the profiles of GSE42568 and GEPIA-BRCA database via bioinformatic method. The upregulated expression of TMEM9A was confirmed in BC samples compared with the paired normal tissues. Hence, we speculated that TMEM9A might promote BC progression. To test the hypothesis, we performed a series of loss/gain-of-function experiments and found that BC cells with TMEM9A deletion inhibited cell proliferation, migration, and invasion along with induced apoptosis. Conversely, TMEM9A overexpression reversed the trend. Mechanically, TMEM9A knockdown blocked the Wnt/β-catenin signaling pathway as evidenced by the increased adenomatous polyposis coli (APC) expression and decreased β-catenin, cyclin D1, and axis inhibition protein 2 (AXIN2) expression. Furthermore, over-activation of the Wnt/β-catenin pathway by transfecting BC cells with β-Catenin-S33Y (β-Catenin tyrosine for serine at codon 33) plasmids reversed the effects caused by TMEM9A knockdown. In conclusion, TMEM9A may play a tumor-promoting role in BC progression via activating the Wnt/β-catenin signaling pathway. Therefore, TMEM9A may be an effective therapeutic option for BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemalebeta CateninWnt Signaling PathwayCell Line, TumorPrognosisCell ProliferationCell MovementGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

breast cancerthe Wnt pathwaytransmembrane protein 9A (TMEM9A)tumorigenesisβ-catenin pathway

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Breast Surgery, the Fourth Hospital of Hebei Medical University.
  • Department of Breast Surgery, Affiliated Hospital of Hebei Engineering University.
  • Breast Center, Cangzhou People's Hospital.
  • Department of Breast Surgery, the Fourth Hospital of Shijiazhuang.

Zitieren

APA

He, J., Bu, Y., Li, X., Zhang, X., & Ma, L. (2023). Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00602

Vancouver

He J, Bu Y, Li X, Zhang X, Ma L. Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00602

BibTeX
@article{He2023,
  author = {He, Jianchao and Bu, Yuhui and Li, Xiaolong and Zhang, Xiaojun and Ma, Li},
  title = {Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/bpb.b22-00602}
}
Kostenlos starten →